Abstract
It appears more and more clear that retinoblastoma (RB) family of proteins represents key molecules in tumour suppression. This family consists of pRb/p105, p107 and pRb2/p130, which participate in a gene regulatory network that governs the cellular response to antimitogenic signals, and whose deregulation constitutes one of the hallmarks of cancer. Irrespective of their structural and biochemical similarities, RB proteins carry out different functional tasks. The expression of RB gene family in the reactive lymphoid tissues again confirms the different role of each member in cell cycle control and differentiation of normal cells. These different functional properties appear to be maintained in tumours lymphoid tissues, where alterations of the RB/p105 gene appear to be relatively rare. In this review, we will summarize the current knowledge about the role of the RB proteins in reactive and neoplastic lymphoid tissue.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bartek J, Bartkova J, Lukas J . (1996). Curr Opin Cell Biol 8: 805–814.
Bartek J, Vojtesek B, Grand RJ, Gallimore PH, Lane DP . (1992). Oncogene 7: 101–108.
Cam H, Dynlacht BD . (2003). Cancer Cell 3: 311–316.
Cinti C, Leoncini L, Nyongo A, Ferrari F, Lazzi S, Bellan C et al. (2000). Am J Pathol 156: 751–760.
Classon M, Dyson N . (2001). Exp Cell Res 264: 135–147.
Claudio PP, De Luca A, Howard CM, Baldi A, Firpo EJ, Koff A et al. (1996). Cancer Res 56: 2003–2008.
Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G et al. (1994). Cancer Res 54: 5556–5560.
Cobrinik D . (2005). Oncogene 24: 2796–2809.
Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J et al. (2002). Leukemia 16: 327–334.
Dimova DK, Dyson NJ . (2005). Oncogene 24: 2810–2826.
Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA . (1993). Cell 73: 499–511.
Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Muller-Hermelink HK, Bentz M et al. (1997). Cancer Res 57: 4608–4614.
Dyson N . (1998). Genes Dev 12: 2245–2262.
Erlanson M, Portin C, Linderholm B, Lindh J, Roos G, Landberg G . (1998). Blood 92: 770–777.
Ewen ME, Xing YG, Lawrence JB, Livingston DM . (1991). Cell 66: 1155–1164.
Flemington EK, Speck SH, Kaelin Jr WG . (1993). Proc Natl Acad Sci USA 90: 6914–6918.
Frolov MV, Dyson NJ . (2004). J Cell Sci 117 (Part 11): 2173–2181.
Garcia JF, Camacho FI, Morente M, Fraga M, Montalban C, Alvaro T et al. (2003). Blood 101: 681–689.
Guo SX, Taki T, Ohnishi H, Piao HY, Tabuchi K, Bessho F et al. (2000). Leuk Res 24: 39–46.
Hanahan DR, Weinberg A . (2000). Cell 100: 57–70.
Helin K, Ed H . (1993). Trends Cell Biol 3: 43–46.
Hoang AT, Lutterbach B, Lewis BC, Yano T, Chou TY, Barrett JF et al. (1995). Mol Cell Biol 15: 4031–4042.
Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL et al. (1996). Am J Pathol 148: 1591–1600.
Kouzarides T . (1995). Semin Cancer Biol 6: 91–98.
Kramer A, Schultheis B, Bergmann J, Willer A, Hegenbart U, Ho AD et al. (2002). Leukemia 16: 1844–1851.
LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS et al. (1997). Genes Dev 11: 847–862.
Lai A, Kennedy BK, Barbie DA, Bertos NR, Yang XJ, Theberge MC . (2001). Mol Cell Biol 21: 2918–2932.
Lazzi S, Bellan C, De Falco G, Cinti C, Ferrari F, Nyongo A et al. (2002). Hum Pathol 33: 723–731.
Lee JO, Russo AA, Pavletich NP . (1998). Nature 391: 859–865.
Leoncini L, Bellan C, Cossu A, Claudio PP, Lazzi S, Cinti C et al. (1999). Clin Cancer Res 5: 4065–4072.
Lindstrom MS, Wiman KG . (2002). Semin Cancer Biol 12: 381–387.
Moller MB, Kania PW, Ino Y, Gerdes AM, Nielsen O, Louis DN et al. (2000). Leukemia 14: 898–904.
Nakayama K, Yamada Y, Koji T, Hayashi T, Tomonaga M, Kamihira S . (2000). Leuk Res 24: 299–305.
Paggi MG, Baldi A, Bonetto F, Giordano A . (1996). J Cell Biochem 62: 418–430.
Putzer BM, Rumpf H, Rega S, Brockmann D, Esche H . (1997). J Virol 71: 9538–9548.
Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S, Watson RJ et al. (2002). Genes Dev 16: 933–947.
Sanchez-Beato M, Martinez-Montero JC, Doussis-Anagnostopoulou TA, Gatter KC, Garcia J, Garcia JF et al. (1996). Br J Cancer 74: 1056–1062.
Sanchez-Beato M, Sanchez-Aguilera A, Piris MA . (2003). Blood 101: 1220–1235.
Sherr CJ, Roberts JM . (1999). Genes Dev 13: 1501–1512.
Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR . (1996). Mol Cell Biol 16: 6965–6976.
Smith EJ, Leone G, Nevins JR . (1998). Cell Growth Differ 9: 297–303.
Stevaux O, Dyson NJ . (2002). Curr Opin Cell Biol 14: 684–691.
Stiegler P, Kasten M, Giordano A . (1998). J Cell Biochem Suppl 30–31: 30–36.
Takahashi Y, Rayman JB, Dynlacht BD . (2000). Genes Dev 14: 804–816.
Taubert S, Gorrini C, Frank SR, Parisi T, Fuchs M, Chan HM et al. (2004). Mol Cell Biol 24: 4546–4556.
Trimarchi JM, Lees JA . (2002). Nat Rev Mol Cell Biol 3: 11–20.
Weinberg RA . (1995). Cell 81: 323–330.
Zukerberg LR, Benedict WF, Arnold A, Dyson N, Harlow E, Harris NL . (1996). Blood 88: 268–276.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leoncini, L., Bellan, C. & De Falco, G. Retinoblastoma gene family expression in lymphoid tissues. Oncogene 25, 5309–5314 (2006). https://doi.org/10.1038/sj.onc.1209619
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209619
Keywords
This article is cited by
-
Telomere dysfunction and cell cycle checkpoints in hematopoietic stem cell aging
International Journal of Hematology (2011)
-
SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies
Molecular Cancer (2010)
-
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Nature Reviews Cancer (2008)